Sign In
Buy EBS
$7.93
-0.280 (-3.41%)
At Close: Jun 03, 2026
MonkeyPox Stocks To Buy Right Now? 3 To Know
09:50am, Tuesday, 02'nd Aug 2022
Should investors be watching these monkeypox stocks right now?
Emergent BioSolutions (EBS) Q2 2022 Earnings Call Transcript
03:30am, Tuesday, 02'nd Aug 2022 The Motley Fool
EBS earnings call for the period ending June 30, 2022.
Emergent Biosolutions (EBS) Reports Q2 Loss, Misses Revenue Estimates
10:15pm, Monday, 01'st Aug 2022 Zacks Investment Research
Emergent Biosolutions (EBS) delivered earnings and revenue surprises of -236.51% and 16.64%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Emergent BioSolutions Inc. (EBS) CEO Bob Kramer on Q2 2022 Results - Earnings Call Transcript
08:07pm, Monday, 01'st Aug 2022
Emergent BioSolutions Inc. (NYSE:EBS ) Q2 2022 Results Conference Call August 1, 2022 5:00 PM ET Company Participants Bob Burrows - Vice President of Investor Relations Bob Kramer - President and Chie
Emergent BioSolutions Reports Financial Results for Second Quarter 2022
08:05pm, Monday, 01'st Aug 2022 GlobeNewswire Inc.
GAITHERSBURG, Md., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the second quarter ended June 30, 2022.
Emergent Biosolutions (EBS) Reports Q2 Loss, Misses Revenue Estimates
07:23pm, Monday, 01'st Aug 2022
Emergent Biosolutions (EBS) delivered earnings and revenue surprises of -236.51% and 16.64%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Monkeypox Stocks GOVX, VRAX, SIGA Rocket on Vaccine Shortage Fears
10:25am, Monday, 01'st Aug 2022
Monkeypox stocks are rallying amid worries about a shortage of vaccines for the illness in the U.S. Additionally, in recent days, New York state, New York City and San Francisco have issued emergency
Why Emergent BioSolutions Stock Is Jumping This Week
08:46pm, Thursday, 28'th Jul 2022 The Motley Fool
Worries about the monkeypox outbreak have driven Emergent's shares higher.
Why Emergent BioSolutions Stock Is Jumping This Week
04:46pm, Thursday, 28'th Jul 2022
Worries about the monkeypox outbreak have driven Emergent's shares higher.
Hot Penny Stocks To Watch As Monkeypox Gets WHO GHE Designation
03:08pm, Monday, 25'th Jul 2022 PennyStocks
If you thought monkeypox was a fad, you might want to reconsider.…
The post Hot Penny Stocks To Watch As Monkeypox Gets WHO GHE Designation appeared first on Penny Stocks to Buy, Picks, News and Inf
WWE, Infrastructure and Energy Alternatives And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
12:06pm, Monday, 25'th Jul 2022 Benzinga
Infrastructure and Energy Alternatives, Inc. (NASDAQ: IEA) shares rose 26% to $13.14 in pre-market trading. MasTec announced plans to acquire Infrastructure and Energy Alternatives for $14 per share i
6 Stocks To Watch As The World Health Organization Declares Monkeypox Outbreak A Global Emergency
07:23pm, Sunday, 24'th Jul 2022 Benzinga
The World Health Organization (WHO) on Saturday declared the monkeypox outbreak a global emergency, its highest level of alert.
WHO Director-General Tedros Adhanom Ghebreyesus said more than 16,0
Emergent BioSolutions to Release Second Quarter 2022 Financial Results and Conduct Conference Call on August 1, 2022
04:05pm, Monday, 18'th Jul 2022
GAITHERSBURG, Md., July 18, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Monday, August 1, 2022, at 5:00 pm eastern time to discuss the financial resu
Emergent BioSolutions and Ridgeback Biotherapeutics Enter Into Agreement for Ebanga™ Treatment for Ebola
08:30pm, Thursday, 07'th Jul 2022 GlobeNewswire Inc.
GAITHERSBURG, Md. and MIAMI, July 07, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into an agreement with Ridgeback Biotherapeutics (“Ridgeba
Emergent BioSolutions Announces Appointment of Sujata Dayal to Board of Directors
08:05pm, Wednesday, 06'th Jul 2022 GlobeNewswire Inc.
GAITHERSBURG, Md., July 06, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that the company’s board of directors appointed Sujata Dayal as a Class II director to se
